High Cost of Treatment for Patients is a Major Restraint for the Growth of the Global MRI Contrast Agent Market

The global MRI contrast agent market is anticipated to grow at a considerable CAGR of 4.2% during the forecast period (2022-2028). The rising frequency of chronic diseases affecting the brain, spine, and liver, as well as the occurrence of joint injuries in developing nations, however, the cost of MRI diagnostic is prohibitive, limiting the use of MRI techniques for diagnosis. As a result, the market's expansion may be slowed. The cost of MRI contrast agents is reasonable, however, the cost of an MRI scan is relatively high. Patients and clinicians alike are hesitant to use MRI for disease diagnosis as a result of this. For instance, In November 2020, Siemens Healthineers has presented a new class of magnetic resonance imaging (MRI) systems that the company named “High-V MRI.” The scanner’s unique combination of digital technologies and the new field strength of 0.55 tesla broadens the range of clinical applications for MRI systems. Magnetom Free. Max considerably improves pulmonary imaging with MRI and allows patients with implants to be scanned much more accurately. Siemens Healthineers has also enlarged the bore size to 80 cm, making the experience more comfortable for patients.

 Browse the full report description “Global MRI Contrast Agent Market Size, Share & Trends Analysis Report by Product Type (Iodinated, Gadolinium, Barium, and Microbubble) and by Indication (Cardiovascular, Neurological, Oncology, Gastrointestinal and others) Forecast 2022-2028“at https://www.omrglobal.com/industry-reports/mri-contrast-media-market

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028

Segment Covered- 

• By Product Type
• By Indication

Regions Covered-

• North America
• Europe
• Asia-Pacific
• Rest of the World

Competitive Landscape- including Bayer AG, Bracco Imaging S.p.A, GE Healthcare, iMax Diagnostic Imaging Ltd., Nano Therapeutics Pvt. Ltd. and others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global MRI Contrast Agent Market Report Segment

By Product Type

• Iodinated
• Gadolinium
• Barium
• Microbubble

By Indication

• Cardiovascular
• Neurological
• Oncology
• Gastrointestinal
• Others

Global MRI Contrast Agent Market Report Segment by Region

North America

• US
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe 

Asia-Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific 

Rest of the World

• Latin America 
• Middle East & Africa